ClinicalTrials.gg
Active, not recruitingNCT07548814Updated Apr 23, 2026

Evaluation of the 2-year AVF Utilization Rate

An observational study in Dialysis Access Dysfunction and Fistulae, sponsored by University Paul Sabatier of Toulouse. Active, not recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-23.

Sponsored by University Paul Sabatier of Toulouse · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
1,000
Ages
18 Years and older
Sex
All
01

Study summary

Arteriovenous fistulas (AVFs) are the standard for dialysis sessions. However, this usually requires surgery before dialysis can begin. Given this pre-operative approach, the investigators evaluate the two-year utilization rate of AVFs and seek to understand why they are still not used in some cases.

02

Conditions studied

  • Dialysis Access Dysfunction
  • Fistulae
03

In context

Lead sponsor

University Paul Sabatier of Toulouse is the lead sponsor of 13 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients for whom the neprhologist indicated an AVF creation

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • First AVF creation

Exclusion criteria

Exclusion Criteria:

  • Minor patient
  • AVF already
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
1,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • AVF creation non dialysed patient

    Procedure: AVF creation as indicated by the nephrologist

Interventions

  • ProcedureAVF creation as indicated by the nephrologist

    AVF are creation in the OR when asked by the nephrologist team

06

What researchers measure

Primary outcomes

  1. AVF utilisation

    AVF puncture

    Time frame: through study completion, an average of 2 years

07

Study locations

1 site
  • Benane Dylan
    Toulouse, 31400, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07548814
Lead sponsor
University Paul Sabatier of Toulouse
Responsible party
Aurélien Hostalrich (MD-PhD, associated Head of vascular surgery departement, University Paul Sabatier of Toulouse) — Principal investigator
First posted
Apr 23, 2026
Start date
Jan 1, 2018
Primary completion
Jan 1, 2026
Completion
Dec 1, 2026 (estimated)
Last update
Apr 23, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion